Last reviewed · How we verify
NCT07000266
The RECOVERY Study: Using Supersaturated Oxygen Therapy To Treat Small Vessel Blockages After a Heart Attack
NA trial testing Percutaneous Coronary Intervention (PCI) in Anterior STEMI in 20 participants. Participants enrolled and being followed up; not accepting new ones.
16 May 2027
Quick facts
| Lead sponsor | Fundacio Privada Mon Clinic Barcelona |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 23 May 2025 |
| Primary completion | 16 May 2027 |
| Estimated completion | 31 December 2027 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Percutaneous Coronary Intervention (PCI)
- Diagnostic Imaging
- Device Treatment
- Follow-up at 30 days
- Follow-up at 60 days
- Follow-up at 12 months
Conditions studied
- Anterior STEMI — all drugs for Anterior STEMI →
Sponsor
Fundacio Privada Mon Clinic Barcelona
Who can join
18 and older, any sex, with Anterior STEMI. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study tests whether adding supersaturated oxygen (SSO₂) therapy to standard stent treatment can improve heart recovery after a major heart attack (anterior STEMI). Adults treated within 6 hours of symptoms will be randomly assigned to receive either standard care or standard care plus SSO₂. The goal is to see if SSO₂ reduces damage to small heart vessels. Heart function will be checked immediately, after one hour, and again at six months. Follow-up visits will track recovery for up to a year.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07000266
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Percutaneous Coronary Intervention (PCI)
Trials testing the same drug.
- NCT06975930 — Outcomes of Different Techniques of Aortoostial Coronary Intervention Assessed by Coronary Computed Tomography Angiograp · NA · not yet recruiting
- NCT05644925 — Effects of Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO) Therapy on miRNAs Expression and Absolute M · NA · withdrawn
- NCT05761067 — STICH-3.0 International Trial Consortium · NA · recruiting
- NCT05329285 — CABG or PCI in Patients With Ischemic Cardiomyopathy · NA · recruiting
- NCT04634240 — Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing · NA · recruiting
Other Fundacio Privada Mon Clinic Barcelona trials
Trials by the same sponsor.
- NCT06607705 — Changes in Eye Pressure in Glaucoma Patients Treated with Istent Inject W, Monitored by a Contact Lens Sensor · NA · recruiting
- NCT06282861 — ANTES B+ Clinical Trial · Phase 4 · terminated
- NCT05644925 — Effects of Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO) Therapy on miRNAs Expression and Absolute M · NA · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07000266 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundacio Privada Mon Clinic Barcelona
- Last refreshed: 2 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07000266.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing